Bro, they haven't even submitted their application
For the FDA to approve a drug (Everage, not CBIS) with serious side effects within six months, suggests that the Cannabis Science should receive similar consideration when we submit our application for the treatment of basal cell carcinoma.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.